https://www.selleckchem.com/pr....oducts/empagliflozin
7%, respectively. The pooled rate of SV-RC was 19.2% for studies with a follow-up longer than 5years. Only three studies provided a thorough report of complication rates after SV-RC. The overall complication rate ranged between 67 and 72% with a 30-day mortality rate of 0-8.8%. The pooled rates of 5 and 10-year disease-free survival after SV-RC were 54.3% and 45.6%, respectively. Approximately one-fifth of patients treated with BST with a curative intent eventually require SV-RC. This procedure carries a proportionally hig
Мне нравится
Комментарий
Перепост
